Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Interest Expenses (2017 - 2018)

Historic Interest Expenses for Cardiff Oncology (CRDF) over the last 7 years, with Q4 2018 value amounting to $232.0.

  • Cardiff Oncology's Interest Expenses fell 9902.04% to $232.0 in Q4 2018 from the same period last year, while for Sep 2019 it was $232.0, marking a year-over-year decrease of 9952.52%. This contributed to the annual value of $2000.0 for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Cardiff Oncology's Interest Expenses is $232.0, which was down 9902.04% from $16.0 recorded in Q3 2018.
  • In the past 5 years, Cardiff Oncology's Interest Expenses ranged from a high of $392414.0 in Q4 2015 and a low of $16.0 during Q3 2018
  • Over the past 4 years, Cardiff Oncology's median Interest Expenses value was $37123.0 (recorded in 2017), while the average stood at $158906.0.
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 809071.86% in 2014, then tumbled by 9995.69% in 2018.
  • Quarter analysis of 4 years shows Cardiff Oncology's Interest Expenses stood at $389871.0 in 2014, then increased by 0.65% to $392414.0 in 2015, then plummeted by 93.96% to $23683.0 in 2017, then crashed by 99.02% to $232.0 in 2018.
  • Its last three reported values are $232.0 in Q4 2018, $16.0 for Q3 2018, and $925.0 during Q2 2018.